Medical Design Technology
Published on Medical Design Technology (https://www.mdtmag.com)

Home > Boston Scientific requests more time as enrollment issues delay MultiSense trial

Boston Scientific requests more time as enrollment issues delay MultiSense trial

Medical device giant Boston Scientific asks the FCC for permission to continue using restricted radio frequencies as the company attempts to complete enrollment in its ongoing MultiSense CRT-D monitoring study.

Boston Scientific logo

Boston Scientific [1] (NYSE:BSX [2]) needs some extra time to complete its MultiSense CRM monitoring study, the company told the Federal Communications Commission in requesting an extended waiver to access a restricted radiofrequency band.

The MultiSense trial, launched in 2010, combines the multi-sensor Cognis model cardiac resynchronization therapy defibrillator with Boston Scientific's Latitude patient management system, which wirelessly transmits data from the CRT-D to the patient's physician.

Content Item Type: 
News [3]
Meta Canonical URL: 
http://www.mdtmag.com/news/2012/10/boston-scientific-requests-more-time-enrollment-issues-delay-multisense-trial
Summary: 
Medical device giant Boston Scientific asks the FCC for permission to continue using restricted radio frequencies as the company attempts to complete enrollment in its ongoing MultiSense CRT-D monitoring study. Boston Scientific (NYSE:BSX) needs some extra time to complete its MultiSense CRM monitoring study, the company told the Federal Communications Commission in requesting an extended waiver to access a restricted radiofrequency band. News Well, Clinical Trials, Cardiac Rhythm Management, Research & Developmentread more
Contributed Author: 
Mass Device
Legacy NID: 
126 196

Deeper Insights

<% if ( rc.ss_related_image_url != null ){ %>
?cmpid=regwallcontent&utm_source=Deeper%20Insights">">
<% } %>

?cmpid=regwallcontent&utm_source=Deeper%20Insights" + ""><%- rc.label %>

<% if ( rc.ss_search_logo != null ){ %>
">
<% } %>
Advertisement
googletag.cmd.push(function() { googletag.display("dfp-ad-clone_of_wallpaper"); });
(function() { var _fbq = window._fbq || (window._fbq = []); if (!_fbq.loaded) { var fbds = document.createElement('script'); fbds.async = true; fbds.src = '//connect.facebook.net/en_US/fbds.js'; var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(fbds, s); _fbq.loaded = true; } _fbq.push(['addPixelId', '745881082149515']); })(); window._fbq = window._fbq || []; window._fbq.push(['track', 'PixelInitialized', {}]);
(function(d,s,i,r) { if (d.getElementById(i)){return;} var n=d.createElement(s),e=d.getElementsByTagName(s)[0]; n.id=i;n.src='//js.hs-analytics.net/analytics/'+(Math.ceil(new Date()/r)*r)+'/1743435.js'; e.parentNode.insertBefore(n, e); })(document,"script","hs-analytics",300000);

Connect with Medical Design Technology

  • Facebook
  • Twitter
  • YouTube

Resources

  • About Us
  • Advertising Info
  • Contact Us
  • Contributor Guidelines
  • Digital Editions
  • Directory FAQs
  • Privacy Policy
  • Product Announcement Form
  • Subscriptions
  • Terms & Conditions

Topics

  • Cardiovascular
  • Diabetes
  • Home Healthcare
  • Implantables
  • Medical Diagnostics
  • Neurology
  • Oncology
  • Orthopedics
  • Pain Management
  • Prosthetics
  • Regenerative Medicine
  • Surgical
  • Wearables

© Copyright 2018 Advantage Business Marketing

var _qevents = _qevents || []; (function() { var elem = document.createElement('script'); elem.src = (document.location.protocol == "https:" ? "https://secure" : "http://edge") + ".quantserve.com/quant.js"; elem.async = true; elem.type = "text/javascript"; var scpt = document.getElementsByTagName('script')[0]; scpt.parentNode.insertBefore(elem, scpt); })(); _qevents.push({ qacct:"p-jsEPJWTckjCbE" });
Quantcast
googletag.cmd.push(function () { googletag.display("dfp-ad-roadblock_modal"); });
"" style="border: 0px; vertical-align: bottom;">
googletag.cmd.push(function() { googletag.display("dfp-ad-roadblock_modal"); });

Source URL: https://www.mdtmag.com/news/2012/10/boston-scientific-requests-more-time-enrollment-issues-delay-multisense-trial

Links
[1] http://www.massdevice.com/company/boston-scientific
[2] http://www.google.com/finance?q=bsx
[3] https://www.mdtmag.com/content-item-types/news